A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrillation (AF) Between 2016 and 2020 in France
Condition: Atrial Fibrillation Interventions: Drug: No OAC; Drug: VKA; Drug: apixaban; Drug: rivaroxaban; Drug: dabigatran Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2023 Category: Research Source Type: clinical trials
